Senseonics sees FY26 revenue $58M-$62M, consensus $60.38M

The company said, “Senseonics (SENS) expects full-year 2026 global net revenue to be approximately $58-$62 million, representing year-over-year growth of 65% to 76%, as the Company completes the transition of Eversense commercialization from Ascensia and brings the entire sales and marketing infrastructure in-house. Gross margins are expected to be approximately 50% for the full year. The financial outlook takes into consideration the following factors: refined plans for commercial transition from Ascensia to Senseonics and the roll-out of Eversense 365 outside the United States, plans with respect to spending on the DTC marketing campaigns to generate leads, the status of other sales and marketing initiatives, and utilization of the patient assistance programs for Eversense 365.”